Skip to main content

Table 1 Clinical features of 289 patients with NB diagnosis

From: Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression

  Mass screening Standard
Characteristics Number (%) Survival (%) Numbers (%) Survival (%)
Total 55 (100) 98 234 (100) 71.3
Gender     
   Female 26 (47.3)   114 (48.7)  
   Male 29 (52.7)   120 (51.3)  
Age     
   Median (range) in months 30 (0-151)   25 (0-183)  
   < 1 year 52 (94.5) 98 73 (31.2) 91.7
   1-5 years 3 (5.5) 100 121 (51.8) 65.2
   > 5 years    40 (17) 52.5
Clinical stage     
   1 16 (29.1) 100 52 (22.2) 94.2
   2 15 (27.2) 93 32 (13.7) 100
   3 9 (16.4) 100 35 (15) 85.7
   4 6 (10.9) 100 97 (41.4) 42.2
   4S 9 (16.4) 100 18 (7.7) 83.3
MYCN oncogene     
   < 10 copies 54 (98.2) 100 160 (82.9) 79.6
   > 10 copies 1 (1.8) 0 33 (18.1) 53.1